The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 BristolMyers Squibb Company  (BMY) Trade Now »     Rate BMY  -  Discuss BMY  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Major Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
85.5%
Top:
100.0%
Rate BMY:



BMY Analysis & Videos »


BMY: Bull or Bear?

Three Favorite Stocks of Wealthy Investors Graphic_rating_buy BMY
+78.09%
in 818 days
By  Steven Halpern   (+19.69%  risk: moderate)  03/23/11 1 comment


Monthly Dividends from a 3-Stock Growth Portfolio Graphic_rating_buy BMY
+0.87%
in 107 days
(closed on 03/23/11)
By  Steven Halpern   (+19.69%  risk: moderate)  12/06/10 1 comment


Bristol-Myers Squibb (BMY): Buying Growth? Graphic_rating_buy BMY
-5.25%
in 68 days
(closed on 12/06/10)
By  Steven Halpern   (+19.69%  risk: moderate)  09/29/10 1 comment


Get free stock alert for BMY:
Your Email Address:


Protective Parents Could Send Mead Johnson Higher Graphic_rating_buy BMY
+82.41%
in 1051 days
By  Wade Hansen   (+51.07%  risk: conservative)  08/02/10 1 comment


Trading FDA, Clinical Trial Binary Events: $BMY $PLX $MKGAY $VVUS $JAZZ $MELA Graphic_rating_buy BMY
Mikerun
73%
+81.91%
in 1072 days
By  Mike Havrilla   (+1.04%  risk: moderate)  07/12/10 122 comments


Skin Cancer Breakthrough Boosts Bristol-Myers Graphic_rating_buy BMY
+5.02%
in 55 days
(closed on 08/02/10)
By  Wade Hansen   (+51.07%  risk: conservative)  06/08/10 1 comment


Bristol-Myers Squibb (BMY): Technical and Fundamental Buy Graphic_rating_buy BMY
+4.43%
in 173 days
(closed on 09/29/10)
By  Steven Halpern   (+19.69%  risk: moderate)  04/09/10 1 comment


Bristol-Myers Squibb (BMY): Time to Buy Pharma Graphic_rating_buy BMY
+7.55%
in 43 days
(closed on 04/09/10)
By  Steven Halpern   (+19.69%  risk: moderate)  02/25/10 1 comment


Get free stock alert for BMY:
Your Email Address:




Turnaround expert targets laggard pharmaceuticals Graphic_rating_buy BMY
+7.17%
in 136 days
(closed on 02/25/10)
By  Steven Halpern   (+19.69%  risk: moderate)  10/12/09 3 comments




Cramer on BloggingStocks: The health care bargain Graphic_rating_buy BMY
+3.66%
in 23 days
(closed on 08/19/09)
By  Jim Cramer   (+25.56%  risk: moderate)  07/27/09 1 comment


FDA Calendar Updates at BioMedReports.com Graphic_rating_buy BMY
Mikerun
73%
+22.55%
in 382 days
(closed on 07/12/10)
By  Mike Havrilla   (+1.04%  risk: moderate)  06/25/09 10 comments


Contrary call on Bristol-Myers (BMY) Graphic_rating_buy BMY
+14.39%
in 158 days
(closed on 10/12/09)
By  Steven Halpern   (+19.69%  risk: moderate)  05/07/09 1 comment


FDA Calendar Updates – Diabetes: AZN, BMY, NVO, Takeda Graphic_rating_buy BMY
Mikerun
73%
+5.13%
in 63 days
(closed on 06/25/09)
By  Mike Havrilla   (+1.04%  risk: moderate)  04/23/09 8 comments





People Bullish on BMY

Radek Zítek
Analyst
N/A
about 1 year ago

Steven Halpern
Tracked Blogger
56%
over 2 years ago

Wade Hansen
Tracked Blogger
N/A
over 2 years ago

rlallen11
Analyst
N/A
over 2 years ago

Mikerun
Mike Havrilla
Principal
73%
over 2 years ago


People Bearish on BMY

seismicstock
Principal
70%
over 3 years ago

dickj
Analyst
N/A
over 4 years ago

Art
Analyst
N/A
over 4 years ago

Fernando Alamo
Analyst
26%
over 5 years ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +32.13% 538
2 18.14 +6.82% 289
3 17.66 +22.47% 85
4 13.47 +13.86% 71
5 12.13 +175.56% 106


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BMY


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About BristolMyers Squibb Company - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch